Precigen, Inc. (PGEN)
4.52
-0.14
(-3.00%)
USD |
NASDAQ |
Nov 13, 16:00
4.52
0.00 (0.00%)
After-Hours: 19:59
Precigen Price : 4.52 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 4.70 | 4.91 | 4.59 | 4.66 | 5.318M |
| Nov 11, 2026 | 4.59 | 4.805 | 4.50 | 4.72 | 4.612M |
| Nov 10, 2026 | 4.61 | 4.72 | 4.40 | 4.52 | 6.032M |
| Nov 09, 2026 | 4.48 | 4.96 | 4.31 | 4.73 | 8.816M |
| Nov 06, 2026 | 4.32 | 4.48 | 4.03 | 4.47 | 9.238M |
| Nov 05, 2026 | 4.71 | 4.74 | 3.92 | 4.22 | 26.65M |
| Nov 04, 2026 | 5.31 | 5.34 | 4.725 | 5.055 | 10.48M |
| Nov 03, 2026 | 5.335 | 5.38 | 5.06 | 5.25 | 9.718M |
| Nov 02, 2026 | 5.36 | 5.48 | 4.905 | 5.14 | 20.62M |
| Oct 30, 2026 | 6.49 | 7.035 | 6.49 | 6.94 | 8.105M |
| Oct 29, 2026 | 6.20 | 6.985 | 6.06 | 6.64 | 7.743M |
| Oct 28, 2026 | 6.06 | 6.345 | 6.03 | 6.08 | 3.674M |
| Oct 27, 2026 | 6.01 | 6.22 | 5.96 | 6.15 | 3.790M |
| Oct 26, 2026 | 6.24 | 6.310 | 6.01 | 6.04 | 2.547M |
| Oct 23, 2026 | 6.35 | 6.38 | 6.15 | 6.19 | 4.347M |
| Oct 22, 2026 | 6.50 | 6.63 | 6.280 | 6.39 | 6.254M |
| Oct 21, 2026 | 6.79 | 6.92 | 6.57 | 6.60 | 5.970M |
| Oct 20, 2026 | 6.62 | 6.945 | 6.51 | 6.83 | 6.174M |
| Oct 19, 2026 | 6.45 | 6.68 | 6.305 | 6.66 | 4.141M |
| Oct 16, 2026 | 7.19 | 7.22 | 6.305 | 6.385 | 5.488M |
| Oct 15, 2026 | 7.31 | 7.55 | 7.17 | 7.195 | 3.953M |
| Oct 14, 2026 | 7.48 | 7.70 | 7.33 | 7.355 | 4.197M |
| Oct 13, 2026 | 7.60 | 7.71 | 7.48 | 7.48 | 2.404M |
| Oct 12, 2026 | 7.77 | 7.87 | 7.63 | 7.66 | 2.163M |
| Oct 09, 2026 | 7.595 | 7.840 | 7.475 | 7.81 | 3.384M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Anika Therapeutics, Inc. | 13.34 |
| Aldeyra Therapeutics, Inc. | 0.6499 |
| Repligen Corp. | 167.77 |
| AC Immune SA | 2.12 |
| Inovio Pharmaceuticals, Inc. | 1.435 |
Price Related Metrics
| PE Ratio | 101.35 |
| PS Ratio | 11.11 |
| Price to Book Value | 19.34 |
| Earnings Yield | 0.99% |
| Market Cap | 1.621B |
| Operating PE Ratio | 51.84 |
| Normalized PE Ratio | 101.35 |